Equity MRK
Friday, May 25, 2018   
Adani Ports  379.90    (2.34%)
 
Asian Paints  1289.65    (-0.04%)
 
Axis Bank  538.45    (0.75%)
 
Bajaj Auto  2759.85    (0.85%)
 
Bharti Airtel  376.65    (1.40%)
 
Coal India  276.05    (-1.36%)
 
Dr Reddy's Lab...  1971.90    (-0.08%)
 
H D F C  1820.00    (0.77%)
 
HDFC Bank  2011.65    (1.30%)
 
Hero Motocorp  3550.70    (1.85%)
 
Hind. Unilever  1575.70    (0.90%)
 
ICICI Bank  296.50    (-0.25%)
 
IndusInd Bank  1914.75    (2.33%)
 
Infosys  1228.80    (0.57%)
 
ITC  271.95    (-1.04%)
 
Kotak Mah. Ban...  1298.25    (1.78%)
 
Larsen & Toubr...  1343.80    (0.38%)
 
M & M  857.30    (1.55%)
 
Maruti Suzuki  8546.85    (1.63%)
 
NTPC  165.10    (0.03%)
 
O N G C  175.35    (4.59%)
 
Power Grid Cor...  211.95    (0.09%)
 
Reliance Inds.  921.75    (0.62%)
 
St Bk of India  267.00    (-0.56%)
 
Sun Pharma.Ind...  466.55    (0.97%)
 
Tata Motors  294.20    (1.82%)
 
Tata Motors-DV...  171.75    (2.05%)
 
Tata Steel  567.20    (3.43%)
 
TCS  3589.45    (-0.43%)
 
Wipro  264.95    (0.28%)
 
Yes Bank  339.45    (2.71%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Corporate News
Suven Life Sciences secures Product Patents in Australia and Singapore
(10:38, 17 May 2018)
Suven Life Sciences announced the grant of two (2) product patents from Australia and one (1) product patent from Singapore corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034.

The granted claims of the patents include the class of selective H3 Inverse agonists and 5HT6 compounds respectively and are being developed as therapeutic agents for major depressive disorders and for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivitydisorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively.

Powered by Capital Market - Live News